BIOMARIN PHARMACEUTICAL INC (BMRN) Earnings History & Surprises
NASDAQ:BMRN • US09061G1013
60.764 USD
-0.12 (-0.19%)
Last: Mar 10, 2026, 10:06 AM
Past quarterly earnings results for BIOMARIN PHARMACEUTICAL INC (BMRN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$0.97
Revenue Estimate796.41M
Last Reported
Release DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported-$0.24
EPS Surprise -137.68%
Revenue Surprise 3.57%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.24 | 0.64 | -137.68% | -137.50% | 874.565M | 844.44M | 3.57% | 17.03% |
| Q3 2025 | -0.16 | 0.38 | -142.18% | -129.09% | 776.133M | 796.24M | -2.53% | 4.08% |
| Q2 2025 | 1.23 | 0.85 | 44.44% | 119.64% | 825.41M | 775.18M | 6.48% | 15.92% |
| Q1 2025 | 0.95 | 0.72 | 31.48% | 106.52% | 745.145M | 755.53M | -1.37% | 14.84% |
| Q4 2024 | 0.64 | 0.54 | 18.42% | 255.56% | 747.313M | 727.71M | 2.69% | 15.65% |
| Q3 2024 | 0.55 | 0.53 | 4.22% | 161.90% | 745.74M | 714.18M | 4.42% | 28.28% |
| Q2 2024 | 0.56 | 0.36 | 57.23% | 93.10% | 712.029M | 675.29M | 5.44% | 19.61% |
| Q1 2024 | 0.46 | 0.35 | 30.72% | 70.37% | 648.833M | 664.82M | -2.40% | 8.79% |
| Q4 2023 | 0.18 | 0.24 | -24.46% | - | 646.207M | 649.62M | -0.53% | 20.22% |
| Q3 2023 | 0.21 | 0.24 | -12.05% | 625.00% | 581.329M | 620.85M | -6.37% | 15.05% |
| Q2 2023 | 0.29 | 0.24 | 22.09% | 93.33% | 595.275M | 607.14M | -1.95% | 11.52% |
| Q1 2023 | 0.27 | 0.18 | 47.54% | 50.00% | 596.415M | 582.04M | 2.47% | 14.83% |
| Q4 2022 | 0.00 | -0.07 | 100.00% | 100.00% | 537.5M | 547.71M | -1.86% | 19.50% |
| Q3 2022 | -0.04 | -0.01 | -361.36% | 80.00% | 505.3M | 528.78M | -4.44% | 23.64% |
| Q2 2022 | 0.15 | 0.12 | 29.99% | 114.29% | 533.8M | 531.9M | 0.36% | 6.40% |
| Q1 2022 | 0.18 | 0.18 | 2.52% | 100.00% | 519.4M | 517.67M | 0.33% | 6.87% |
| Q4 2021 | -0.32 | -0.33 | 2.37% | -366.67% | 449.8M | 451.23M | -0.32% | -0.51% |
| Q3 2021 | -0.20 | -0.25 | 20.94% | -104.99% | 408.7M | 444.03M | -7.96% | -14.28% |
| Q2 2021 | 0.07 | -0.12 | 158.23% | 450.00% | 501.7M | 457.47M | 9.67% | 16.81% |
| Q1 2021 | 0.09 | -0.07 | 231.05% | -79.55% | 486M | 455.38M | 6.72% | -3.21% |
| Q4 2020 | 0.12 | -0.19 | 161.70% | - | 452.1M | 449.03M | 0.68% | - |
| Q3 2020 | 4.01 | 1.26 | 218.06% | - | 476.8M | 463.74M | 2.82% | - |
| Q2 2020 | -0.02 | -0.10 | 79.94% | - | 429.5M | 426.99M | 0.59% | - |
| Q1 2020 | 0.44 | 0.05 | 723.70% | - | 502.1M | 478.15M | 5.01% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-50.99%
Max EPS beat (4)
44.44%
Min EPS beat (4)
-142.18%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
1.54%
Max Revenue beat (4)
6.48%
Min Revenue beat (4)
-2.53%
Analysis
In the last 4 quarters, BMRN has beaten EPS estimates in 2 out of 4 releases
BMRN has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, BMRN reported -51.0% below the EPS estimates on average.
In the last 4 quarters, BMRN has beaten the revenue estimates by 1.5% on average.
BIOMARIN PHARMACEUTICAL INC / BMRN Earnings FAQ
Can you provide the last earnings date for BIOMARIN PHARMACEUTICAL INC?
BIOMARIN PHARMACEUTICAL INC (BMRN) last reported earnings on 2/23/2026.
Did BMRN stock beat earnings estimates in the most recent quarter?
BIOMARIN PHARMACEUTICAL INC (BMRN) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often BIOMARIN PHARMACEUTICAL INC beats earnings estimates?
In the last 4 quarters, BIOMARIN PHARMACEUTICAL INC (BMRN) has beaten EPS estimates in 2 out of 4 releases.